These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13311212)

  • 1. [Non-specific anti-inflammatory therapy with bacteriostatic drugs in evolutive pulmonary tuberculosis; first conclusions based on three-year experience].
    FAVEZ G; AGUET F
    Rev Tuberc; 1955 Dec; 19(12):1400-11. PubMed ID: 13311212
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-inflammatory drugs: ACTH, cortisone and pyrazole derivatives in the treatment of pleuro-pulmonary tuberculosis].
    VIC-DUPONT
    Vie Med; 1955 Nov; 36(11):1212-6. PubMed ID: 13282208
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications for hydrocortisone and prednisone in the treatment of evolutive pulmonary tuberculosis; 4 years experience based on 70 cases].
    AGUET F; FAVEZ G
    Schweiz Med Wochenschr; 1956 Jul; 86(30):843-51. PubMed ID: 13360177
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-inflammatory medication in the treatment of human tuberculosis].
    PESTEL M
    Vie Med; 1955 Dec; 36(Spec No):66-8. PubMed ID: 13299628
    [No Abstract]   [Full Text] [Related]  

  • 5. [Summary and conclusions on the application of hydrazide in the different evolutive phases of pulmonary tuberculosis].
    VELEZ RUIZ J
    Rev Esp Tuberc; 1953 May; 22(218):237-40. PubMed ID: 13100986
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the double anti-inflammatory and hormonal aspect of cortisonic therapy in advanced chronic pulmonary tuberculosis].
    ZAPATERO J; ZAPATERO A; GARCIA MORENO F; MONTURIOL JM; CAMARERO F; BLANCO RODRIGUEZ JA
    Rev Clin Esp; 1959 Oct; 75():88-97. PubMed ID: 13847012
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative anti-inflammatory properties of p-hydroxyphenylbutazone and of dexamethasone in pulmonary tuberculosis].
    FAVEZ G; PIOLINO M; BONSTEIN H
    Schweiz Med Wochenschr; 1962 Apr; 92():460-3. PubMed ID: 13891854
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-specific stimulation therapy in evolutive pulmonary tuberculosis; use of stimulating substances].
    FAVEZ G; AGUET F; BOSSY A
    Schweiz Z Tuberk; 1955; 12(5):324-35. PubMed ID: 13311491
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of a synthetic anti-inflammatory drug in the treatment of pleuropulmonary tuberculosis].
    GUILLERMAND J; TIZZANI RJ; SERRADIMIGNI A
    Therapie; 1955; 10(4):591-602. PubMed ID: 13299215
    [No Abstract]   [Full Text] [Related]  

  • 10. [Decongestive action of streptomycin in evolutive pulmonary tuberculosis; radiologic study].
    PANNIER R
    Acta Tuberc Belg; 1950 Aug; 41(4):264-81. PubMed ID: 14783010
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our results of the treatment of hematogenous pulmonary tuberculosis with combined hormones and bacteriostatic agents].
    POPOVIC J; MILETIC V; BJEGOVIC M; MACANOVIC M; ILIC L; PRASO R
    Tuberkuloza; 1959; 11():215-9. PubMed ID: 14434154
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of the treatment of sero-cavernous pulmonary tuberculosis with nitrogen mustard with simultaneous application of small doses of bacteriostatic drugs].
    ZABORSKI F
    Pol Tyg Lek (Wars); 1953 Apr; 8(16):590-6. PubMed ID: 13073633
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACTH-bacteriostatic therapy for pulmonary tuberculosis].
    REALE M; GARAVENTA A; PAOLI G; COSTA G
    Minerva Med; 1956 Apr; 47(32):1205-17. PubMed ID: 13334083
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined anti-inflammatory and antituberculous chemotherapy in one medication; clinical and therapeutic study].
    PESTEL M; RAVINA A
    Presse Med (1893); 1956 Sep; 64(69):1577-9. PubMed ID: 13379288
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bacteriostatic activity of 4-amino-5-iodosalicylic acid towards Koch's bacillus and first results in the treatment of pulmonary tuberculosis].
    PALERMO G
    Riforma Med; 1950 Dec; 64(49):1335-8. PubMed ID: 14809150
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of evolutive pulmonary tuberculosis by short infusions of PAS administered daily and twice daily].
    FAVEZ G; AGUET F; BOSSY A
    Schweiz Z Tuberc Pneumonol; 1956; 13(1):1-33. PubMed ID: 13351602
    [No Abstract]   [Full Text] [Related]  

  • 17. [Success and danger of bacteriostatic therapy in pulmonary tuberculosis].
    FRISCH A
    Wien Klin Wochenschr; 1954 Jun; 66(23):408-12. PubMed ID: 13187966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic trends in very grave and evolutive forms of pulmonary tuberculosis].
    POZZI G; SCOCCIA S
    Minerva Med; 1955 Nov; 46(94):1496-9. PubMed ID: 13288053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-inflammatory drugs in the treatment of pulmonary, pleural and meningeal tuberculosis; indications].
    PARAF J; PARAF M
    Sem Hop; 1956 Jul 26-30; 32(44-45):2499-501. PubMed ID: 13360309
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined treatment of tuberculosis with bacteriostatic and vagotonic substance].
    TRAUTWEIN-MARBURG H
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 106(3):301-4. PubMed ID: 14925062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.